You just read:

Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune Therapy

News provided by

Eli Lilly and Company; Nektar Therapeutics

Jul 24, 2017, 07:30 ET